Consider automation early in the rollout of clinical translation and scale up of clinical-trial protocols.
Yaling Shi
Advertisement
Yaling Shi is senior manager R&T, Lonza Inc.
Articles by Yaling Shi
Advertisement
Latest Updated Articles
End-to-End Cell Therapy Automation: An Immunotherapy Case StudyPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
3
Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing
4
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
5
